Trovagene prices $4.5M follow-on

On Dec. 15, cancer company Trovagene Inc. (NASDAQ:TROV) raised $4.5 million through the sale of 15 million units at $0.30 in a follow-on underwritten by H.C. Wainwright. Each unit comprises a share an...